{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:58:15Z","timestamp":1761512295111},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.bone.2006.07.027","type":"journal-article","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T16:09:23Z","timestamp":1158682163000},"page":"236-241","source":"Crossref","is-referenced-by-count":19,"title":["A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: Description of the biochemical response of FGF23 to octreotide therapy and surgery"],"prefix":"10.1016","volume":"40","author":[{"given":"Marianne S.","family":"Elston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge J.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roderick","family":"Clifton-Bligh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John V.","family":"Conaglen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2006.07.027_bib1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1172\/JCI108855","article-title":"Osteomalacia due to 1\u03b1,25-dihydroxycholecalciferol deficiency: association with a giant cell tumour of bone","volume":"60","author":"Drezner","year":"1977","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2006.07.027_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/0003-4819-93-2-279","article-title":"Vitamin D metabolite levels in oncogenic osteomalacia","volume":"93","author":"Sweet","year":"1980","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.bone.2006.07.027_bib3","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1359\/jbmr.1997.12.9.1502","article-title":"Tumor-induced osteomalacia: clinical and basic studies","volume":"12","author":"Shane","year":"1997","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.07.027_bib4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0002-9343(87)90711-X","article-title":"Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia","volume":"83","author":"Reid","year":"1987","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bone.2006.07.027_bib5","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1210\/jc.2002-021919","article-title":"Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia","volume":"88","author":"Nelson","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2006.07.027_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2106\/00004623-198971020-00017","article-title":"Osteomalacia secondary to osteosarcoma","volume":"71","author":"Cheng","year":"1989","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2006.07.027_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF03343720","article-title":"Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia","volume":"23","author":"Huang","year":"2000","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.bone.2006.07.027_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathological entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"1","author":"Folpe","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bone.2006.07.027_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00003086-198907000-00033","article-title":"Oncogenic osteomalacia: a case report","volume":"244","author":"McGuire","year":"1989","journal-title":"Clin. Orthop."},{"key":"10.1016\/j.bone.2006.07.027_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00003072-199902000-00016","article-title":"Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia","volume":"24","author":"Nguyen","year":"1999","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.bone.2006.07.027_bib11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2265.2001.01056.x","article-title":"Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy","volume":"54","author":"Rhee","year":"2001","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bone.2006.07.027_bib12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","article-title":"Localisation of mesenchymal tumours by somatostatin receptor imaging","volume":"359","author":"Jan de Beur","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2006.07.027_bib13","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","article-title":"Octreotide therapy for tumor-induced osteomalacia","volume":"345","author":"Seufert","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2006.07.027_bib14","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJM200205303462215","article-title":"Octreotide for tumor-induced osteomalacia (letter)","volume":"346","author":"Paglia","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2006.07.027_bib15","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl. Acad. Sci."},{"key":"10.1016\/j.bone.2006.07.027_bib16","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2006.07.027_bib17","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2006.07.027_bib18","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.bone.2003.12.025","article-title":"Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna","volume":"34","author":"Ward","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2006.07.027_bib19","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","article-title":"Serum FGF23 in normal and disordered phosphorus homeostasis","volume":"18","author":"Weber","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2006.07.027_bib20","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","article-title":"Transgenic mice expressing fibroblast growth factor 23 under the control of the \u03b11(I) collagen promoter exhibit growth retardation, osteomalacia and disturbed phosphate homeostasis","volume":"145","author":"Larsson","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2006.07.027_bib21","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1074\/jbc.M207872200","article-title":"Human fibroblast growth factor-23 mutant suppress Na+-dependent phosphate co-transport activity and 1\u03b1,25-dihydroxyvitamin D3 production","volume":"278","author":"Saito","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2006.07.027_bib22","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.M210490200","article-title":"The autosomal dominant hypophosphataemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency","volume":"278","author":"Bai","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2006.07.027_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","article-title":"FGF-23 transgenic mice demonstrate hypophosphataemic rickets with reduced expression of sodium phosphate cotransporter type IIa","volume":"314","author":"Shimada","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2006.07.027_bib24","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1210\/en.2004-0233","article-title":"Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders","volume":"145","author":"Bai","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2006.07.027_bib25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2006.07.027_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","article-title":"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphataemia","volume":"14","author":"Benet-Pages","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2006.07.027_bib27","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1210\/jc.2004-2238","article-title":"A novel recessive mutation in fibroblast growth factor-23 (FGF23) causes familial tumoral calcinosis","volume":"90","author":"Larsson","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2006.07.027_bib28","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI18563","article-title":"Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent","volume":"112","author":"Berndt","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2006.07.027_bib29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/geno.2000.6235","article-title":"MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia","volume":"67","author":"Rowe","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.bone.2006.07.027_bib30","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1172\/JCI200319687","article-title":"Evidence for a bone-kidney axis regulating phosphate homeostasis","volume":"112","author":"Quarles","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2006.07.027_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00041552-200209000-00011","article-title":"New insights into phosphate homeostasis: fibroblast growth factor 23 and frizzled-related protein-4 are phosphaturic factors derived from tumors associated with osteomalacia","volume":"11","author":"Kumar","year":"2002","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"10.1016\/j.bone.2006.07.027_bib32","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.M408903200","article-title":"Circulating FGF23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo","volume":"280","author":"Saito","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2006.07.027_bib33","doi-asserted-by":"crossref","first-page":"c94","DOI":"10.1159\/000086347","article-title":"Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism","volume":"101","author":"Nishi","year":"2005","journal-title":"Nephron. Clin. Pract."},{"key":"10.1016\/j.bone.2006.07.027_bib34","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2006.07.027_bib35","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/jc.2005-2105","article-title":"Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia","volume":"91","author":"Imel","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2006.07.027_bib36","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1210\/jc.2004-0357","article-title":"Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors","volume":"90","author":"Carpenter","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2006.07.027_bib37","first-page":"53","article-title":"Tumor-related osteomalacia followed after treatment by hyperparathyroidism","volume":"66","author":"Heylen","year":"1999","journal-title":"Rev. Rhum. (Engl. Ed.)"},{"key":"10.1016\/j.bone.2006.07.027_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-130-4-199902160-00008","article-title":"Hypocalcemia associated with alendronate (letter)","volume":"130","author":"Schussheim","year":"1999","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.bone.2006.07.027_bib39","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJM200304103481521","article-title":"Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency","volume":"348","author":"Rosen","year":"2003","journal-title":"N. Engl. J. Med."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328206005916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328206005916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T22:33:59Z","timestamp":1683585239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328206005916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S8756328206005916"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2006.07.027","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}